Please select the option that best describes you:
Topics:
Genitourinary Cancers • Medical Oncology
Do you consider use of TIP as first-line therapy for poor-risk advanced germ cell tumors?
Based on a recent single-arm phase II trial, is there a role for paclitaxel, ifosfamide, and cisplatin (TIP) as a first-line regimen instead of BEP?
Answer from: Medical Oncologist at Community Practice
Unequivocally no. TIP seems clearly more toxic and achieves results no different than VIP or BEP given at high volume centers. TIP will not ever be compared to either and is going nowhere.
In my view and the view of other testis cancer experts, the most important aspect is that these un...
Sign in or Register to read more